tiprankstipranks
Trending News
More News >
Conmed (CNMD)
NYSE:CNMD
US Market
Advertisement

Conmed (CNMD) Technical Analysis

Compare
197 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Conmed’s (CNMD) Moving Averages Convergence Divergence (MACD) indicator is -1.71, suggesting Conmed is a Sell.
Conmed’s (CNMD) 20-Day exponential moving average is 46.43, while Conmed’s (CNMD) share price is $45.19, making it a Sell.
Conmed’s (CNMD) 50-Day exponential moving average is 49.00, while Conmed’s (CNMD) share price is $45.19, making it a Sell.

Conmed (CNMD) Pivot Points

Oct 19, 2025, 11:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
42.33
42.98
43.97
44.63
45.62
46.27
47.26
Fibonacci
42.98
43.61
44.00
44.63
45.26
45.64
46.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Conmed (CNMD) Moving Averages

Oct 19, 2025, 11:06 AM
Period
Simple
Exponential
MA5
44.51Buy
44.83Buy
MA10
44.95Buy
45.18Buy
MA20
46.16Sell
46.43Sell
MA50
50.44Sell
49.00Sell
MA100
51.53Sell
51.48Sell
MA200
55.87Sell
56.51Sell
Conmed’s (CNMD) 10-Day exponential moving average is 45.18, while Conmed’s (CNMD) share price is $45.19, making it a Buy.
Conmed’s (CNMD) 100-Day exponential moving average is 51.48, while Conmed’s (CNMD) share price is $45.19, making it a Sell.
Conmed’s (CNMD) stock price is $45.19 and Conmed’s (CNMD) 50-day simple moving average is 50.44, creating a Sell signal.
Conmed’s (CNMD) stock price is $45.19 and Conmed’s (CNMD) 100-day simple moving average is 51.53, creating a Sell signal.
Conmed’s (CNMD) stock price is $45.19 and Conmed’s (CNMD) 200-day simple moving average is 55.87, creating a Sell signal.

Conmed (CNMD) Technical Indicators

Oct 19, 2025, 11:06 AM
Name
Value
Implied Action
RSI (14)
41.29
Neutral
STOCH (9,6)
45.80
Neutral
STOCHRSI (14)
40.04
Neutral
MACD (12,26)
-1.71
Sell
ADX (14)
31.67
Neutral
Williams %R
-54.68
Buy
CCI (14)
-55.38
Neutral
ATR (14)
1.63
-
Ultimate Oscillator
45.60
Neutral
ROC
-1.05
Sell
Conmed’s (CNMD) Relative Strength Index (RSI) is 41.29, creating a Neutral signal.
Conmed’s (CNMD) Trend Strength Indicator (ADX) is 31.67, creating a Neutral signal.
Conmed’s (CNMD) Commodity Channel Index (CCI) is -55.38, creating a Neutral signal.
Conmed’s (CNMD) Price Rate of Change (ROC) is -1.05, creating a Sell signal.

FAQ

Is CNMD a Buy, Hold, or Sell?
Based on CNMD’s technical indicators, CNMD is a Sell.
    What is CNMD’s RSI (14)?
    CNMD’s RSI (14) is 41.29, which suggests CNMD is a Neutral.
      What is CNMD’s MACD?
      CNMD’s MACD is -1.71, which suggests CNMD is a Sell.
        What is CNMD’s 5-day moving average?
        CNMD’s 5-day moving average is 44.51, which suggests CNMD is a Buy.
          What is CNMD’s 20-day moving average?
          CNMD 20-day moving average is 46.16, which suggests CNMD is a Sell.
            What is CNMD’s 50-day moving average?
            CNMD’s 50-day moving average is 50.44, which suggests CNMD is a Sell.
              What is CNMD’s 200-day moving average?
              CNMD’s 200-day moving average is 55.87, which suggests CNMD is a Sell.
                What is CNMD’s Williams % R (14)?
                CNMD’s Williams % R (14) is -54.68, which suggests CNMD is a Buy.
                  What is CNMD’s CCI (14)?
                  CNMD’s CCI (14) is -55.38, which suggests CNMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis